These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32219214)

  • 1. Kidney-Type Glutaminase Inhibitor Hexylselen Selectively Kills Cancer Cells via a Three-Pronged Mechanism.
    Ruan JJ; Yu Y; Hou W; Chen Z; Fang J; Zhang J; Ni M; Li D; Lu S; Rui J; Wu R; Zhang W; Ruan BH
    ACS Pharmacol Transl Sci; 2019 Feb; 2(1):18-30. PubMed ID: 32219214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable self-assembly micelles significantly enhanced the solubility, biological stability and
    Fang J; Chen Z; Song J; Li J; Han Y; Hou W; Wang W; Ruan BH
    RSC Chem Biol; 2021 Dec; 2(6):1669-1681. PubMed ID: 34977582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diselenide Covalent Allosteric Inhibitors of Glutaminase with Strong
    Hou W; Chen Z; Pan C; Ni M; Ruan H; Song J; Lu S; Bhasin A; Ruan BH
    ACS Med Chem Lett; 2023 Jul; 14(7):920-928. PubMed ID: 37465295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebselen: Mechanisms of Glutamate Dehydrogenase and Glutaminase Enzyme Inhibition.
    Yu Y; Jin Y; Zhou J; Ruan H; Zhao H; Lu S; Zhang Y; Li D; Ji X; Ruan BH
    ACS Chem Biol; 2017 Dec; 12(12):3003-3011. PubMed ID: 29072450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of biotinylated Hexylselen as a probe to identify KGA allosteric inhibitors by a convenient biomolecular interaction assay.
    Hou W; Fang J; Su L; Ye H; Ruan BH
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2498-2502. PubMed ID: 31324513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomolecular Interaction Assays Identified Dual Inhibitors of Glutaminase and Glutamate Dehydrogenase That Disrupt Mitochondrial Function and Prevent Growth of Cancer Cells.
    Zhu M; Fang J; Zhang J; Zhang Z; Xie J; Yu Y; Ruan JJ; Chen Z; Hou W; Yang G; Su W; Ruan BH
    Anal Chem; 2017 Feb; 89(3):1689-1696. PubMed ID: 28208301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Assembled Micellar Glutaminase Allosteric Inhibitor for Effective Therapeutic Intervention.
    Fang J; Chen Z; Li J; Li D; Wang W; Ruan BH
    Int J Nanomedicine; 2022; 17():213-225. PubMed ID: 35058693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminase.
    Yang KY; Wu CR; Zheng MZ; Tang RT; Li XZ; Chen LX; Li H
    Bioorg Chem; 2019 Nov; 92():103186. PubMed ID: 31465967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity.
    Chen Z; Li D; Xu N; Fang J; Yu Y; Hou W; Ruan H; Zhu P; Ma R; Lu S; Cao D; Wu R; Ni M; Zhang W; Su W; Ruan BH
    J Med Chem; 2019 Jan; 62(2):589-603. PubMed ID: 30543285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel tellurodibenzoic acid compounds as kidney-type glutaminase (KGA) inhibitors.
    Hou W; Zhou Y; Rui J; Bai R; Bhasin AKK; Ruan BH
    Bioorg Med Chem Lett; 2019 Jul; 29(13):1673-1676. PubMed ID: 31076348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physapubescin, a natural withanolide as a kidney-type glutaminase (KGA) inhibitor.
    Cheng L; Wu CR; Zhu LH; Li H; Chen LX
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1243-1246. PubMed ID: 28174105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue.
    Song J; Pan C; Li J; Bai R; Zeng Z; Han Y; Chen Z; Hou W; Li Y; Ruan BH
    ACS Med Chem Lett; 2023 Jan; 14(1):11-17. PubMed ID: 36655131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A natural inhibitor of kidney-type glutaminase: a withanolide from
    Wu C; Zheng M; Gao S; Luan S; Cheng L; Wang L; Li J; Chen L; Li H
    Oncotarget; 2017 Dec; 8(69):113516-113530. PubMed ID: 29371926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
    Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
    Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).
    Robinson MM; McBryant SJ; Tsukamoto T; Rojas C; Ferraris DV; Hamilton SK; Hansen JC; Curthoys NP
    Biochem J; 2007 Sep; 406(3):407-14. PubMed ID: 17581113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel allosteric site employs a conserved inhibition mechanism in human kidney-type glutaminase.
    Shankar S; Ramachandran S; Tulsian N; Radhakrishnan S; Jobichen C; Sivaraman J
    FEBS J; 2023 May; 290(9):2437-2448. PubMed ID: 36259273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFα increases STAT3-mediated expression of glutaminase isoform KGA in cultured rat astrocytes.
    Milewski K; Bogacińska-Karaś M; Hilgier W; Albrecht J; Zielińska M
    Cytokine; 2019 Nov; 123():154774. PubMed ID: 31344597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration.
    Li Y; Peer J; Zhao R; Xu Y; Wu B; Wang Y; Tian C; Huang Y; Zheng J
    Transl Neurodegener; 2017; 6():10. PubMed ID: 28439409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-specific BNIP-2-homology protein Caytaxin relocalises glutaminase to neurite terminals and reduces glutamate levels.
    Buschdorf JP; Li Chew L; Zhang B; Cao Q; Liang FY; Liou YC; Zhou YT; Low BC
    J Cell Sci; 2006 Aug; 119(Pt 16):3337-50. PubMed ID: 16899818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
    Masamha CP; LaFontaine P
    J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.